Bortega

Bortezomib is a medication used for certain types of cancer treatment. It works by interfering with cancer cell growth and is administered intravenously or subcutaneously.

Bortezomib is primarily used in the treatment of multiple myeloma and mantle cell lymphoma. It is often prescribed when other treatments have not been effective. The medication targets specific proteins in cancer cells, helping to slow or stop their growth. Patients may wonder, 'What is Bortezomib used for?' and the answer lies in its role as a targeted therapy for these specific cancers.

Common effects of Bortezomib may include fatigue, nausea, and peripheral neuropathy. Some patients may experience diarrhea or constipation. These effects can vary in severity and duration. It's important to discuss any persistent or severe side effects with a healthcare provider.

Bortezomib should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions closely. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Proper storage and handling are crucial to maintain the medication's effectiveness.

Bortezomib may interact with other medications, including those that affect the liver's ability to metabolize drugs. It is important to discuss all current medications with a healthcare provider before starting Bortezomib. Alcohol and certain supplements may also interact with Bortezomib, so patients should be cautious and consult their healthcare provider for personalized advice.